Vicore Pharma Holding AB (VCRE) Stock Ticker
Market factors today
Unlock the full VCRE picture
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
VCRE stock facts
| Ticker symbol | VCRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $2.7B |
| CEO | Ahmed Mousa |
| Employees | 37 |
| Headquarters | Stockholm, AB, SE |
| IPO date | 2026-07-02 |
| Website | vicorepharma.com |
What you can see for VCRE on Tickr
Live VCRE price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VCRE report.
Rankings
FAQ
What is the ticker symbol for Vicore Pharma Holding AB?
The ticker symbol for Vicore Pharma Holding AB is VCRE, listed on the NASDAQ.
What is VCRE?
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.